Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-23

Clinical Trial Update: Amygdala Insula Retraining in the Management of Multiple Sclerosis Symptoms [NA]

View source ↗

Summary

This entry notes that a clinical trial evaluating amygdala-insula retraining for managing Multiple Sclerosis symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chronic Conditions Research Fund | Conditions: Multiple Sclerosis | NA | Status: COMPLETED